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ARTICLE
Gli1 identiﬁes osteogenic progenitors for bone
formation and fracture repair
Yu Shi1, Guangxu He1,2, Wen-Chih Lee1, Jennifer A. McKenzie1, Matthew J. Silva1 & Fanxin Long1,3
Bone formation in mammals requires continuous production of osteoblasts throughout life. A
common molecular marker for all osteogenic mesenchymal progenitors has not been iden-
tiﬁed. Here, by lineage-tracing experiments in fetal or postnatal mice, we discover that Gli1+
cells progressively produce osteoblasts in all skeletal sites. Most notably, in postnatal
growing mice, the Gli1+ cells residing immediately beneath the growth plate, termed here
“metaphyseal mesenchymal progenitors” (MMPs), are essential for cancellous bone for-
mation. Besides osteoblasts, MMPs also give rise to bone marrow adipocytes and stromal
cells in vivo. RNA-seq reveals that MMPs express a number of marker genes previously
assigned to mesenchymal stem/progenitor cells, including CD146/Mcam, CD44, CD106/
Vcam1, Pdgfra, and Lepr. Genetic disruption of Hh signaling impairs proliferation and
osteoblast differentiation of MMPs. Removal of β-catenin causes MMPs to favor adipogen-
esis, resulting in osteopenia coupled with increased marrow adiposity. Finally, postnatal Gli1+
cells contribute to both chondrocytes and osteoblasts during bone fracture healing. Thus Gli1
marks mesenchymal progenitors responsible for both normal bone formation and fracture
repair.
DOI: 10.1038/s41467-017-02171-2 OPEN
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Osteoblastogenesis in humans and mice occurs throughoutlife during not only bone modeling that begins in theembryo and continues well after birth but also bone
remodeling that takes place in the mature skeleton. However, the
molecular identity of the osteogenic mesenchymal progenitors is
not well understood. Extensive work has been devoted to the
postnatal bone marrow stromal cells (BMSCs) as they were his-
torically shown to contain cells, now commonly referred to as
mesenchymal stem cells (MSCs), that can proliferate in vitro to
form ﬁbroblast colonies, which in turn can produce bone and
cartilage in diffusion chambers or generate bone organs complete
with a hematopoietic marrow when grafted in vivo1–5. Work in
the past two decades with cell sorting techniques has revealed that
cell surface markers for MSCs are likely complex and variable
especially following expansion in vitro6, 7. Nonetheless, Pdgfra
and Sca-1 have been useful for prospective enrichment of MSCs
in the mouse8. Recently, an AlphaV+CD200+ cell population
isolated from the bones of newborn mice was shown to posses the
capacity to form bone, cartilage, and stromal cells when trans-
planted into the kidney capsules of immunodeﬁcient mice, but
how this population relates to the bone marrow MSCs is not
clear9.
Recent experiments with lineage-tracing techniques have pro-
vided important insights about skeletal progenitor cells in vivo.
Perinatal Sox9+, Col2+, Acan+, or Osx+ cells have all been shown
to produce osteoblasts and BMSCs in both growing and adult
(4 months of age) mice10, 11. However, it is not clear how those
perinatal progenitors relate to the Lepr+ stromal cells that
generate osteoblasts mainly in adult mice12, 13. Distinct from the
Lepr+ stromal cells that are present throughout the marrow
cavity, a Gremlin-positive (Grem1+) progenitor population was
found to reside underneath the growth plate but appeared to have
limited contribution to the adult bone14. In addition, αSMA+ cells
in juvenile mice (4–5 weeks of age) have been shown to produce
osteoblasts, but their long-term contribution to bone was not
determined15. Overall, the prior work has highlighted the het-
erogeneity and complexity of skeletal progenitors in postnatal
mice.
Indian Hedgehog (Ihh) signaling critically regulates osteoblast
differentiation during endochondral bone development in the
embryo. Ihh, one of the three Hedgehog (Hh) proteins in
mammals, signals via the seven-pass transmembrane protein
Smoothened (Smo) to modulate gene expression by either acti-
vating or derepressing the Gli1–3 transcription factors16. Inter-
estingly, Gli1 is not only a transcription activator but also a target
gene of Gli proteins, thus amplifying the transcriptional response
to Hh signaling. Ihh regulates osteoblast differentiation both
indirectly by controlling cartilage development and directly
through signaling to the perichondrial progenitors17, 18. More-
over, the direct osteogenic function of Ihh involves both activa-
tion of Gli2 and derepression of Gli3 and is further augmented by
Gli119, 20. Hh signaling has also been implicated in bone for-
mation in postnatal mice, as deletion of Ihh from the growth plate
chondrocytes in newborn mice caused continuous loss of trabe-
cular bone at an older age21. Conversely, forced activation of Hh
signaling caused by either global Ptc1 haploinsufﬁciency or Ptc1
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Fig. 1 Embryonic Gli1+ cells give rise to multiple cell types in postnatal mice. Gli1-CreERT2; Ai9 mice were administered tamoxifen (TM) at E13.5 and
harvested at E14.5 a–d, E18.5 e–g, or 2 months of age h–l. Red: tdTomato+ cells; blue: nuclear staining by DAPI. Scale bars: 100 µm a, d,m, q, s or 500 µm e,
g, h, l, n, p. a–c, e–f, h, k Representative confocal images from frozen sections of the femur. Boxed areas are shown at a higher magniﬁcation in
corresponding panels to the right b, c, f, i–k. Rv Ranvier’s groove, SM skeletal muscle, GP growth plate. 1°: primary ossiﬁcation center; 2°: secondary
ossiﬁcation center. Green arrow: chondrocytes in growth plate; white arrow: osteocyte; yellow arrow: osteoblast on periosteal surface. d, g, l H&E staining
of sister sections corresponding to a, e, and h, respectively. m–o Representative confocal images from frozen sections through the lambdoid suture m or
lumbar vertebrae n, o. Boxed area in n is shown at a high magniﬁcation in o. P parietal bone, Ip interparietal bone. p H&E staining of an adjacent section to
n. q–t Immunoﬂuorescence staining of Perilipin q, r or Lepr s, t on frozen sections of distal metaphyseal q, r or diaphyseal s, t bone marrow region of the
femur. Boxed areas in q and s are shown at a high magniﬁcation in r and t, respectively. Arrowheads in r denote tdTomato+ adipocytes. Numbers in t
indicate percentage (mean± SD, n= 3) of tdTomato+Lepr+ over total tdTomato+ cells on two sections per mouse and three mice for each genotype
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deletion in mature osteoblasts enhanced bone formation in
postnatal mice22, 23. These studies, however, do not address the
physiological function of Hh signaling in the maintenance or
differentiation of osteoblast progenitors in postnatal mice. By
utilizing the Gli1-CreERT2 mouse expressing a tamoxifen (TM)-
inducible form of Cre (CreERT2) from the endogenous Gli1 locus,
recent studies have indicated that Gli1 marks “MSCs” in the
craniofacial bones, the incisor as well as several internal organs of
adult mice24–27. However, the potential relationship between Gli1
and postnatal skeletal progenitors in the long bones has not been
investigated.
Here we demonstrate that Gli1+ cells progressively produce
essentially all osteoblasts in the murine skeleton. Whereas
osteoblasts in the secondary ossiﬁcation center and the bone shaft
are mostly descendants of embryonic Gli1+ cells, the cancellous
bone osteoblasts in the primary ossiﬁcation center of postnatal
mice are produced from Gli1+ “metaphyseal mesenchymal pro-
genitors” (MMPs) residing immediately below the growth plate.
RNA proﬁling of the MMPs by RNA-seq reveals a molecular
signature enriched with multiple cell-surface markers associated
with MSCs, including CD146/Mcam, CD44, and CD106/Vcam1.
In addition, postnatal Gli1+ cells contribute to chondrocytes and
osteoblasts during bone fracture healing. Thus Gli1-lineage cells
encompass osteogenic mesenchymal progenitors responsible for
not only normal bone formation but also fracture repair.
Results
Gli1-lineage cells are principle precursors for osteoblasts. To
investigate the contribution of Hh-responsive cells to the skele-
ton, we traced the fate of Gli1-expressing cells in mice with the
genotype of Gli1-CreERT2; Ai9 by administering TM at the
selected times before harvest at different ages. Previous studies
have indicated that nuclear Cre activity from the Gli1-CreERT2
allele is limited to cells actively responding to Hh at the time of
TM administration or approximately 24 h after27. We term those
cells Gli1+ cells. In our system, both Gli1+ cells and their des-
cendants (Gli1-lineage cells) are permanently marked by
expression of the red ﬂuorescent protein tdTomato. In the ﬁrst set
of experiments, we administered TM at E13.5 before the
appearance of mature osteoblasts in the endochondral skeleton
and harvested the mice at E14.5, E18.5, or postnatal 2 months of
age. At E14.5, Gli1+ cells were found predominantly in the
perichondrium encasing the cartilage anlage, with relatively few
in the cartilage proper (Fig. 1a, d). The perichondrial Gli1+ cells
were present in multiple layers covering the joint surface, the
Ranvier’s groove, and the shaft where osteoblasts ﬁrst form
around E14.5 (Fig. 1b, c). The abundance of Gli1+ cells in the
perichondrium corresponded well with Gli1 mRNA expression at
E14.5 as previously detected by in situ hybridization, but the
number of Gli1+ chondrocytes observed here was lower than
expected, perhaps due to poor availability of TM to the cartilage
proper at this stage18. When the mice were analyzed at E18.5,
tdTomato+ cells were most prominent in the primary ossiﬁcation
center occupying the mid-section of the long bone (Fig. 1e–g). At
2 months after birth, tdTomato+ cells were abundant throughout
the cortical bone, as well as the cancellous bone in both primary
and secondary ossiﬁcation centers of the long bone (Fig. 1h, l,
i–k). High-magniﬁcation images indicated that the positive cells
included both osteoblasts on the bone surface and osteocytes
embedded in the bone matrix, as well as some growth plate
chondrocytes (Fig. 1j, k). Similarly, most osteoblasts and osteo-
cytes in the skull and vertebrae expressed tdTomato (Fig. 1m–p).
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Fig. 2 Postnatal Gli1+ cells contribute to osteoblasts in both endochondral and intramembranous bones. Gli1-CreERT2; Ai9 mice were treated with TM at
1 month of age and analyzed at 24 h a, b, k, l, q; 1 month c, d, m, n; 3 months e–g; or 9 months h–j, o, p, r after the last TM dosing. Representative images
from three mice for each time point are presented. Red: tdTomato+ cells; blue: nuclear staining by DAPI. Scale bars: 500 µm a–o or 100 µm q, r.
a–p Representative confocal images of frozen sections of the femur. Boxed areas are shown at a high magniﬁcation in corresponding panels to the right. GP
growth plate. Green arrow: trabecular bone. CB cortical bone, M marrow. q, r Representative confocal image showing sections through the lambdoid suture
of the skull. P parietal bone, Ip interparietal bone
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At all the skeletal sites examined, some muscle ﬁbers were also
positive (Fig. 1h–p). Within the bone marrow of long bones,
tdTomato marked many adipocytes as identiﬁed by perilipin
immunostaining and also contributed to the stromal component
(Fig. 1q, r). Interestingly, 70–80% of the tdTomato+ BMSCs
expressed leptin receptor (Lepr) (Fig. 1s, t). Thus embryonic
Gli1+ cells give rise to multiple cell types associated with the
skeleton and are a major source of osteoblasts in both fetal and
postnatal life of the mouse.
We next examined whether postnatal Gli1+ cells continued to
be a source of osteoblasts. To this end, we administrated three
daily doses of TM to the Gli1-CreERT2; Ai9 mice starting at
1 month of age and tracked the tdTomato+ cells after 1, 3, or
9 months of chasing. Analyses at 24 h after the last dosing
identiﬁed Gli1+ cells in four distinct domains: the articular
cartilage, the upper layers of the growth plate, the perichondrium
ﬂanking the growth plate, as well as the chondro-osseous junction
immediately beneath the growth plate (Fig. 2a, b). No tdTomato
was detected in either cortical or cancellous bone or within the
marrow, indicating no detectable Hh signaling in mature
osteoblasts or osteocytes or the bone marrow cells. Notably, after
1 month of chasing, not only did the tdTomato+ domain below
the growth plate expand considerably but the signal also extended
to the surface of numerous bone trabeculae within the primary
ossiﬁcation center, likely indicating the production of tdTomato+
osteoblasts (Fig. 2c). The tdTomato+ chondrocytes also expanded
but did not yet reach the full thickness of the growth plate at this
time (Fig. 2d). After 3 months of chasing, tdTomato was detected
throughout the height of the growth plate, whereas the positive
domain under the growth plate was reduced from that of the
tdTomato
ColI-GFP
DAPI 8.89±2.36% 86.13±4.9%80.42±5.9%
a
3 months 1 month24 h
TM at 1 month
b c d e f
tdTomato
ColI-GFP
DAPI
g
1 month24 h
TM at 1 month
h i j
q
0
10
20
30
40
0
2
4
6
8
10
0
0.02
0.04
0.06
0.08
0.1
0
0.1
0.2
0.3
0.4
*
*
*
B
V
/T
V
 (
%
)
T
b.
 N
 (
/m
m
)
T
b.
 T
h
(m
m
)
T
b.
 S
p
(m
m
)
Before After
Ctrl DTA
m n
0
20
40
60
0
20
40
60
*
p
P
IN
P
 (
ng
/m
l)
C
T
X
-I
 (
ng
/m
l)
Ctrl DTA
k l
tdTomato
DAPI 0
10
20
30
40
50
DTA
B
V
/T
V
 (
%
)
*
o
Ctrl
DTACtrl DTACtrl DTACtrl DTACtrl DTACtrl DTACtrl
Fig. 3 Gli1+ cells are critical for cancellous bone formation in postnatal mice. a–j Postnatal Gli1+ cells produce osteoblasts. Gli1-CreERT2; Ai9; ColI-GFP mice
were treated with TM at 1 month of age and analyzed at 24 h a, b, g, h; 1 month c, d, i, j; or 3 months e, f after the last TM dosing. Representative confocal
images are shown for tibia a–f and lumbar vertebrae g–j. Boxed areas are shown at a higher magniﬁcation in corresponding panels to the right. Percentage
(mean± SD, n= 3) of tdTomato+GFP+ over total GFP+ cells a–f was calculated from cancellous bone region extending 300 µm from growth plate on two
sections each of three mice. Scale bar: 500 µm. k–q Postnatal Gli1+ cells are necessary for cancellous bone formation. DTA (Gli1-CreERT2; Ai9; Rosa-DTA)
or Ctrl (Gli1-CreERT2; Ai9) littermates were treated with TM once daily for 3 consecutive days starting at 1 month of age and harvested at 3 weeks after last
dosing. k, l Loss of tdTomato+ cells in the distal femur of DTA (l) compared to Ctrl mice (k) at the time of harvest. Scale bar: 500 µm. m, n Representative
μCT images from cancellous bone of distal femur. o Quantiﬁcation of cancelluous bone mass (BV/TV) by µCT in distal femur. p Serum levels of P1NP (left)
and CTX-I (right) at the time of harvest. q In vivo microCT analyses of cancellous bone parameters in distal femur of mice immediately before TM (white
bar, “Before”) or immediately before harvest (black bar, “After”). BV/TV bone volume over tissue volume, Tb.N trabeculae number, Tb.Th trabeculae
thickness, Tb.Sp trabeculae spacing. n= 3, *p< 0.05, paired Student's t-tests
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earlier time point (Fig. 2e, f). Importantly however, tdTomato
continued to decorate the surface of bone trabeculae in the
primary ossiﬁcation center (Fig. 2g). At 9 months after TM
dosing, the growth plate remained tdTomato+ but was reduced in
height (Fig. 2h, i). Moreover, the tdTomato+ domain under the
growth plate all but disappeared, concurrent with a marked
decrease of bone trabeculae in the primary ossiﬁcation center at
this age (Fig. 2i). Nonetheless, most osteoblasts and osteocytes of
the remaining bone trabeculae expressed tdTomato (Fig. 2j).
Distinct from the earlier time points, tdTomato+ cells became
notable in the bone marrow at this time. In contrast, no
tdTomato was detected in either the bony tissue or marrow of the
secondary ossiﬁcation center at any time point following TM at
1 month. Throughout 9 months of chasing, the tdTomato+
articular chondrocytes consistently occupied the 3–4 cell layers
closest to the joint surface. In addition, although no tdTomato
was detected in the cortical bone at 24 h after TM, positive cells
appeared in certain areas of the periosteum after 1 month of
chasing (Fig. 2k–n). After 9 months, tdTomato spread to more
areas of the periosteal surface (Fig. 2o, p). More importantly,
some osteocytes within the cortical bone expressed tdTomato at
this age (Fig. 2p). Finally, in the skull, tdTomato+ cells were
initially concentrated in the interior of the lambdoid suture or the
posterior frontal suture at 24 h after TM (Fig. 2q, Supplementary
Figure 1). After 9 months of chasing, tdTomato clearly marked
both the bone surface and the osteocytes near the lambdoid
suture (Fig. 2r). Overall, the Gli1+ cells in postnatal growing mice
continue to produce osteoblasts in both endochondral and
intramembranous bones.
We next chose to focus our study on the Gli1+ cells below the
growth plate. To corroborate that those cells give rise to
osteoblasts in the primary ossiﬁcation center, we fate-mapped
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frozen sections of proximal tibia. Boxed area shown at a higher magniﬁcation to the right. Arrowheads in h denote Pdgfra+tdTomato+ cells. Scale bar:
100 µm g. i FACS analyses of Lepr (left) or Pdgfra (right) expression among CD31−CD45−Ter119−tdTomato+ cells from the cancellous bone region beneath
the growth plate of either distal femur or proximal tibia. Red and blue lines represent control IgG and speciﬁc antibody, respectively. j–o Confocal images of
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DAPI signal was omitted in k, m, o for better visualization. Scale bar: 100 µm. p FACS analyses of Lepr (left) or Pdgfra (right) expression among CD31
−CD45−Ter119−tdTomato+ from the bone marrow. Red and blue lines represent the control and speciﬁc antibody, respectively. Quantiﬁcation is presented
as mean± SD, n= 3. q–t Confocal images of immunoﬂuorescence staining for perilipin on frozen sections of distal femur. Boxed areas are shown at higher
magniﬁcation to the right. Percentage (mean± SD, n= 3) of perilipin+tdTomato+ over perilipin+ adipocytes was acquired from cancellous bone region
extending 400 µm from the growth plate in two sections each of three mice. Scale bar: 500 µm. u–z Confocal images showing Gli1+ cells (red) and
immunoﬂuorescence signal of Aggrecan (green) in distal femur of Gli1-CreERT2;Ai9 mice treated with TM at different ages and harvested after 24 h. Scale
bar: 500 µm. Boxed areas are shown at higher magniﬁcation to the right v, x, z. (AA) Differential expression of MSC marker genes in Gli1+ MMPs vs. Gli1−
mesenchymal cells. Heatmap generated from RNA-seq data of three paired biological replicates. Scale derived from voom-transformed data indicating
relative increase (red) or decrease (blue) in MMPs
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Gli1-linege cells in mice expressing green ﬂuorescent protein
(GFP) speciﬁcally in osteoblasts. Speciﬁcally, we generated mice
with the genotype of Gli1-CreERT2; Ai9; ColI-GFP and applied
TM at 1 month of age. Analyses at 24 h conﬁrmed that GFP
marked many osteoblasts of the cancellous bone as expected
(Fig. 3a). Importantly, <10% of the tdTomato+ cells under the
growth plate co-expressed GFP, indicating that most of the Gli1+
cells were not mature osteoblasts (Fig. 3b). However, after
1 month of chasing, >80% of the tdTomato+ cells now expressed
GFP (Fig. 3c, d). As the tdTomato+ chondrocytes had not yet
reached the chondro-osseous junction after 1-month chasing, the
double-positive osteoblasts were most likely derived from the Gli1
+ cells below the growth plate. After 3 months of chasing, the
percentage of double positive among tdTomato+ cells below the
growth plate remained similar (~86%), even though now entire
columns of growth plate chondrocytes expressed tdTomato
(Fig. 3e, f). Similarly, in vertebrae, the Gli1+ cells beneath the
cartilage endplate were initially negative for GFP but differ-
entiated to GFP+ osteoblasts after 1 month of chasing (Fig. 3g–j).
Thus the Gli1+ cells under the growth plate are a major source of
osteoblasts in supporting cancellous bone formation in postnatal
mice.
To assess the contribution of the osteogenic Gli1+ cells to bone
mass, we genetically ablated those cells by inducing expression of
the cytotoxic diphtheria toxin A (DTA). Speciﬁcally, we applied
TM to either Gli1-CreERT2;Ai9;Rosa-DTA (DTA mice) or Gli1-
CreERT2;Ai9 mice (Ctrl mice) at 1 month of age and harvested
the bones after 3 weeks. Sections of the distal femur from the
DTA mice contained markedly fewer tdTomato+ cells than the
Ctrl mice, conﬁrming the effectiveness of the cell ablation
technique (Fig. 3k, l). Importantly, three-dimensional (3D)
reconstruction of μCT images revealed that the cancellous bone
was notably less in the DTA mice (Fig. 3m, n). Quantiﬁcation
conﬁrmed a signiﬁcant decrease in bone volume/tissue volume
(BV/TV) in the DTA mice (Fig. 3o). The deﬁcit in bone mass was
likely due to defective bone formation as the serum propeptide of
type I procollagen (P1NP) level was signiﬁcantly lower in the
DTA mice immediately before sacriﬁce, whereas the bone
resorption marker C-telopeptide (CTX-I) was similar between
the genotypes (Fig. 3p). To monitor potential changes in the
cancellous bone of each mouse during the 3 weeks, we performed
in vivo μCT with the distal femur immediately before TM
treatment and again before the harvest. Whereas the Ctrl mice
exhibited a notable increase in bone mass (BV/TV) and
trabecular number (Tb. N) and decrease in trabecular spacing
(Tb. Sp), the DTA mice showed no changes in those parameters
during this time (Fig. 3q). Together, the data so far support that
the Gli1+ cells below the growth plate are functionally important
for supporting cancellous bone formation in postnatal mice.
Gli1 marks postnatal “metaphyseal mesenchymal progenitors”.
We then sought to characterize the osteogenic Gli1+ cells under
the growth plate in 1-month-old mice. Immunoﬂuorescent
staining of endomucin demarcated the vasculature in both pri-
mary and secondary ossiﬁcation centers and showed that Gli1+
cells nestled among the metaphyseal blood vessels immediately
under the growth plate but were clearly distinct from the endo-
thelial cells (Fig. 4a, b). Immunostaining of intracellular aggrecan
conﬁrmed that the Gli1+ cells were also separate from the growth
plate chondrocytes expressing the proteoglycan (Fig. 4c, d).
Although recent studies have shown that Lepr marks osteoblast
progenitors in the bone marrow of adult mice, we found that few
of the Gli1+ cells beneath the growth plate (~7%) expressed Lepr
detectable by immunostaining (Fig. 4e, f). As Pdgfra is a common
marker for mesenchymal progenitors, we examined its potential
expression in the Gli1+ cells. For this, we took advantage of the
Pdgfra-GFP allele that expressed GFP from the 3ʹ-untranslated
region of the endogenous Pdgfra locus and generated mice with
the genotype of Gli1-CreERT2; Ai9; Pdgfra-GFP. Administration
of TM at 1 month of age showed that most (~80%) of the Gli1+
cells under the growth plate expressed Pdgfra and therefore were
likely mesenchymal progenitors (Fig. 4g, h). To conﬁrm the
expression proﬁle of Lepr and Pdgfra among the Gli1+ cells, we
isolated the cells from the chondro-osseous junction of the long
bones at 24 h after TM and performed ﬂuorescence-activated cell
sorting (FACS) analyses with antibodies against the endogenous
proteins. In keeping with the immunostaining results, among the
tdTomato+ mesenchymal population (CD31−CD45−Ter119
−tdTomato+) <10% expressed Lepr but >60% was Pdgfra-positive
(Fig. 4i). To gain further insight about the progenitors along the
osteoblast lineage, we examined the expression of Runx2 and Osx
and observed positive signal in ~70% of the Gli1+ progenitors for
Runx2 but only ~20% for Osx at 1 month of age (Fig. 4j–m). On
the other hand, no Sox9 signal was detected in the Gli1+ pro-
genitors, indicating that they were separate from the chondro-
genic lineage (Supplementary Figure 3A–C). In keeping with the
progression of osteoblast differentiation, after 1 month of chasing,
Table 1 Relative expression of MSC cell surface markers in Gli1+ MMPs over Gli1− mesenchymal cells isolated from the chondro-
osseous junction of one-month-old mice
gene_name logFC CI.L CI.R AveExpr t adj.P.Val LinearFC
Vcam1 1.43E+00 1.238381579 1.62E+00 6.90E+00 1.73E+01 2.44E−06 2.689604
Mcam 1.15E+00 0.623453805 1.67E+00 1.06E+00 5.02E+00 2.98E−03 2.214369
Cd44 6.68E−01 0.570826489 7.64E-01 8.51E+00 1.58E+01 3.97E−06 1.588379
Pdgfra 1.06E+00 0.535143995 1.58E+00 1.44E+00 4.64E+00 4.53E−03 2.082435
Pdgfrb 4.41E−01 0.090816963 7.91E−01 1.88E+00 2.89E+00 3.89E−02 1.357405
Lepr 7.36E−01 0.252759698 1.22E+00 1.21E+00 3.49E+00 1.77E−02 1.665826
Acta2 3.32E−01 0.094708473 5.68E−01 3.43E+00 3.21E+00 2.54E−02 1.258329
Cspg4 −1.59E+00 −1.884728395 −1.30E+00 5.21E+00 −1.24E+01 1.53E−05 −3.012349
Ly6a −3.33E−02 −0.358501759 2.92E−01 3.02E+00 −2.34E−01 8.63E−01 −1.023329
RNA-seq results from three paired pools of Gli1+ vs. Gli1− mesenchymal cells isolated from the chondro-osseous junction of one-month-old mice
Adj.P.Val: adjusted p-value
LinearFC: linear fold change (Gli1+ over Gli1− cells)
logFC: estimate of the log2-fold-change
CI.L: left limit of conﬁdence interval for logFC
CI.R: right limit of conﬁdence interval for logFC
AveExpr: average log2-expression for the feature (gene or isoform) over all samples
t: moderated t-statistic
adj.P.Value: adjusted p-value using the Benjamini–Hochberg method (most stringent statistical signiﬁcance). p<5.00E−02 considered statistically signiﬁcant
LinearFC: estimate of the linear fold-change
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the Osx+ population among the Gli1-lineage cells increased to
~50% (Fig. 4n, o). The results so far therefore establish the Gli1+
cells beneath the growth plate as osteogenic mesenchymal
progenitors.
In our chasing experiments, we consistently observed a
progressive increase of tdTomato+ cells within the bone marrow
proper. Whereas there was no tdTomato signal in the bone
marrow of 1-month-old mice at 24 h after TM, positive cells were
readily detectable after 9 months of chasing (Fig. 2j). We
therefore decided to assess the potential expression of Lepr and
Pdgfra among the tdTomato+ BMSCs (CD31−CD45−Ter119−
tdTomato+) by FACS analyses. In contrast to the Gli1+
progenitors that expressed little Lepr, ~50% of the Gli1-lineage
BMSCs were Lepr-positive after 6 months of chasing (Fig. 4p,
left). On the other hand, the Pdgfra expression proﬁle was similar
between the Gli1-lineage bone marrow cells after chasing and the
initial Gli1+ progenitors, with both at ~60% (Fig. 4p, right,
compare with Fig. 4i, right). Therefore, the Gli1+ mesenchymal
progenitors beneath the growth plate, besides being osteoblast
precursors, are likely to produce BMSCs expressing Lepr or
Pdgfra or both in adult mice. We next assessed whether the Gli1-
lineage-derived BMSCs were enriched for ﬁbroblast colony-
forming units (CFU-F). For this, we performed CFU-F assays
with BMSCs after 3 months of chasing following TM induction at
1 month of age. We found no difference between the percentage
of tdTomato+ CFU-F (2.1%± 0.23%, SD, n = 3) and the
percentage of tdTomato+ BMSCs (1.8%± 0.4%, SD, n = 3). Thus
the Gli1-lineage-derived BMSCs exhibit a similar colony-forming
ability to the bulk BMSCs.
As adipocytes are an important constituent of the adult bone
marrow, we next investigated whether the Gli1+ mesenchymal
progenitors also produce bone marrow adipocytes in vivo.
Perilipin immunoﬂuorescent staining detected no signal in
Gli1+ cells in 1-month-old mice, indicating that mature
adipocytes in the bone marrow did not experience Hh signaling
(Fig. 4q, r). Remarkably, after 3 months of chasing, ~30% of the
perilipin+ adipocytes located within the distal metaphyseal region
of the femur expressed tdTomato, indicating their origin from the
Gli1+ cells (Fig. 4s, t). Taken together, the data so far demonstrate
that the Gli1+ mesenchymal progenitors can give rise to
osteoblasts, BMSCs as well as bone marrow adipocytes and
therefore are at least tri-potent in vivo.
The study so far has focused on 1 month of age, a stage when
mice are rapidly growing. We next examined whether the Gli1+
progenitor pool changes with aging. Because we noted that the
cancellous bone mass notably decreased after 4 months of age, we
administered TM to the Gli1-CreERT2; Ai9 mice at 1, 2, 4, or
12 months of age and monitored the Gli1+ cells after 24 h. We
performed immunoﬂuorescent staining against aggrecan to mark
the growth plate, a critical landmark for locating the Gli1+
progenitors of interest. By using a modiﬁed protocol that detects
both intracellular and extracellular aggrecan, we detected
aggrecan deposition both within and below the growth plate in
1-month-old mice (Fig. 4u, v). This staining pattern was
strikingly different from that of intracellular aggrecan shown
earlier and marking only aggrecan-producing cells (Fig. 4c, d),
thus supporting the view that cartilage matrix remnants serve as a
scaffold for nascent bone matrix deposition during endochondral
ossiﬁcation. Importantly, at 1 month of age, numerous Gli1+ cells
were distributed among the aggrecan-containing matrix below
the growth plate (Fig. 4v). By 4 months, however, few Gli1+ cells
were present under the growth plate, concurrent with the
disappearance of the aggrecan-containing matrix from the
cancellous bone region (Fig. 4w, x). At 12 months of age,
essentially no Gli1+ cells were detectable even though the growth
plate was present (Fig. 4y, z). Thus the Gli1+ mesenchymal
progenitors beneath the growth plate are abundant in the young
postnatal mice but diminish precipitously with age. To assess
whether changes in proliferation could account for the decline in
the Gli1+ progenitor pool, we performed a proliferation assay by
injecting 5-ethynyl-2ʹ-deoxyuridine (EdU) into 1- or 2-month-old
mice at 24 h after TM and 4 h before harvest. The results showed
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that the Gli1+ mesenchymal progenitors at the chondro-osseous
junction exhibited a similar proliferation index of ~30% between
1 and 2 months of age, indicating that a mechanism other than
proliferation is likely responsible for the rapid loss of the Gli1+
progenitors with age (Supplementary Figure 2). We also detected
a similar proliferation rate (~20%) among the Gli1+ growth-plate
chondrocytes between the two ages. In contrast, the Gli1+
articular chondrocytes exhibited no proliferation (Supplementary
Figure 2). As a previous study using the Nestin-GFP mice showed
a similar age-dependent decrease for nestin+ cells under the
growth plate, we performed nestin immunostaining to examine a
potential relationship between the Gli1+ and the nestin+ cells28.
We, however, observed no overlap between the two populations
in either 1-month- or 1-year-old mice (Supplementary Figure 3D,
E). Overall, based on their anatomical location and their tri-
potential for differentiation in vivo, we designate the Gli1+ cells
immediately under the growth plate of juvenile mice MMPs.
To gain a better understanding of the molecular identity of
MMPs, we compared its RNA proﬁle with that of the Gli1−
mesenchymal cells from the same region. Speciﬁcally, we
performed RNA-seq experiments with FACS-sorted Gli1+
(CD31−CD45−Ter119−tdTomato+) vs. Gli1− (CD31−CD45−
Ter119−tdTomato−) cells from the chondro-osseous junction of
the distal femur in 1-month-old Gli1-CreERT2; Ai9 mice
harvested at 24 h after TM. The data revealed that the Gli1+
MMPs were signiﬁcantly enriched in mRNA for a number of
markers previously assigned to MSCs, including CD44, CD106/
Vcam1, CD146/Mcam, Pdgfra, Pdgfrb, and αSma/Acta2 (Fig. 4aa,
Table 1). Interestingly, Lepr mRNA was also enriched in MMPs
even though immunostaining did not detect the protein in most
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of the cells (Fig. 4aa, f). On the other hand, another MSC marker
Sac-1/Ly6a, or the pericyte marker NG2/Cspg4, was not
preferentially expressed by MMPs (Fig. 4aa, Table 1). Thus the
Gli1+ MMPs identiﬁed here express multiple but not all markers
previously identiﬁed in mesenchymal stem/progenitor cells.
Hh signaling controls MMP proliferation and differentiation.
Gli1 expression could simply be a marker for MMPs or could
indicate a physiological function for Hh signaling in those cells.
To distinguish those possibilities, we genetically deleted Smo, an
obligatory mediator of Hh signaling, from the Gli1+ cells in
postnatal mice. Brieﬂy, mice with the genotype of either Gli1-
CreERT2; Ai9 (Ctrl) or Gli1-CreERT2; Ai9; Smoc/c (SmoCKO)
were treated with TM once daily for 3 consecutive days starting at
1 month of age and harvested them at 10 days after the last TM
dosing. The mice appeared to be normal and did not exhibit
obvious distress at the time of harvest. Micro-computed tomo-
graphy (µCT) imaging and quantiﬁcation of the cancellous bone
in the distal femur detected lower bone mass (BV/TV) and tra-
becular bone number (Tb. N) coupled with increased trabecular
spacing (Tb. Sp) in SmoCKO over Ctrl mice (Fig. 5a, b). On the
other hand, serum CTX-I levels were similar between the geno-
types, indicating normal bone resorption in the SmoCKO mice.
Thus Hh signaling is required for normal cancellous bone accrual
in juvenile mice.
We next examined the cellular effect of Smo deletion in MMPs.
The overall pool size of MMPs and their descendants (tdTomato+)
was markedly reduced in the SmoCKO mice (Fig. 5c). EdU
labeling assays revealed that Smo deletion decreased proliferation
among the tdTomato+ cells (Fig. 5c, d). In addition, Smo deletion
diminished the percentage of the tdTomato+ cells transitioned to
the preosteoblast stage as marked by Osx expression (Fig. 5e, f).
These results demonstrate that Hh signaling is necessary for
normal proliferation and osteoblast differentiation of MMPs and/
or their progeny cells.
β-Catenin deletion switches MMP fate towards adipogenesis.
We next examined the potential role of β-catenin in mediating
osteoblast differentiation of MMPs. Previous work has established
that Wnt/β-catenin signaling functions downstream of Hh to
regulate osteoblastogenesis in the mouse embryo29, 30. In addi-
tion, postnatal deletion of β-catenin in Osx+ cells not only
reduced bone mass but also increased bone marrow adiposity31,
32. Here we treated mice with the genotype of either Gli1-
CreERT2; Ai9 (Ctrl) or Gli1-CreERT2; Ai9; β-cateninc/c
(βcatCKO) with TM once daily for 3 days starting at 1 month of
age and analyzed them at 1 month after the last TM dosing. µCT
imaging revealed that β-catenin deletion signiﬁcantly reduced
cancellous bone mass in the distal femur (Fig. 6a). Quantitative
analyses indicated that the decrease in bone mass (BV/TV) was
due to reduced trabecular number (Tb. N) but no change in
trabecular thickness (Tb. Th) resulting in increased trabecular
spacing (Tb. Sp) (Fig. 6b). On the contrary, the cortical bone
parameters in βcatCKO mice were all normal (Fig. 6c). This result
was consistent with the earlier observation that there was little
targeting of the cortical bone by Gli1-CreERT2 after 1 month of
chasing (see Fig. 2f). Histology revealed a virtual lack of cancel-
lous bone in the metaphysis of βcatCKO mice (Fig. 6d). The
osteopenia was unlikely due to increased bone resorption as the
serum CTX-I level was normal in the mutant mouse (Fig. 6e).
These results therefore demonstrate that β-catenin in MMPs is
critical for supporting cancellous bone formation in postnatal
mice.
We next examined whether loss of β-catenin affected other
differentiation fates of MMPs. Histology of the femur indicated a
notable increase in adipocytes (identiﬁable by round and clear
morphology) in place of cancellous bone at the metaphysis in
βcatCKO mice (Fig. 6d). More importantly, the MMP-derived
adipocytes as demarcated by tdTomato were both more
numerous and bigger in the βcatCKO mouse over the control
(Fig. 6f). Quantiﬁcation conﬁrmed that β-catenin signiﬁcantly
increased both number and size of the marrow adipocytes
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(Fig. 6g, h). To assess speciﬁcally whether β-catenin deletion
affected the relative contribution of MMPs to total marrow
adipocytes, we performed immunoﬂuorescence staining for
perilipin to mark all mature adipocytes and quantiﬁed the
percentage of tdTomato+perilipin+ cells (MMP-derived) over
total perilipin+ cells. Whereas the MMPs normally produced
~10% of the marrow adipocytes after 1 month of chasing, they
accounted for up to ~50% when β-catenin was deleted (Fig. 6i).
Thus loss of β-catenin appears to alter the fate decisions of MMPs
to favor adipogenesis at the expense of bone formation.
Gli1+ cells contribute to fracture healing. The data so far have
demonstrated that Gli1 marks MMPs critical for normal bone
formation in postnatal mice. To test whether Gli1+ cells in
postnatal mice also contribute to bone regeneration, we created a
semistabilized fracture at the diaphysis of the femur to observe
fracture healing. We ﬁrst marked the Gli1+ cells in Gli1-CreERT2;
Ai9 mice with TM at 1 month of age and then subjected the mice
to fracture at 10 weeks of age, before harvesting them after
10 days of healing. In agreement with our earlier observation in
non-injured mice, the contralateral non-fractured femur exhib-
ited prominent tdTomato expression in the articular cartilage and
the metaphysis but no signal in the cortical bone except for
occasional areas of the periosteum (Fig. 7a). Following extraction,
however, strong tdTomato was detected throughout the fracture
callus including both the bony and cartilaginous regions
(Fig. 7b–d). Immunoﬂuorescent staining for intracellular aggre-
can indicated that ~63% of aggrecan+ chondrocytes were also
tdTomato+ (Fig. 7c). Similarly, immunostaining of osteocalcin
(Ocn) showed that ~50% of the Ocn+ osteoblasts within a bony
callus region expressed tdTomato (Fig. 7e, f). These data indicate
that Gli1 marks a major skeletal progenitor pool contributing to
both bone and cartilage formation during bone fracture healing in
postnatal mice.
Discussion
Through genetic lineage-tracing experiments, we have provided
evidence that the Gli1+ cells are a predominant source for
osteoblasts throughout the life of a mouse. Whereas the
embryonic Gli1+ cells give rise to essentially all osteoblasts in both
fetal and postnatal skeleton, a pool of postnatal Gli1+ cells
immediately beneath the growth plate, termed MMPs in the
present study, are essential for cancellous bone formation in
juvenile mice. The study therefore identiﬁes Gli1 as a common
molecular marker among most if not all mesenchymal progeni-
tors destined to become osteoblasts in the mouse.
Several features about MMPs are worth noting. The cells are at
least tri-potent, producing osteoblasts, BMSCs as well as bone
marrow adipocytes in vivo. By immunostaining, most MMPs
express Pdgfra and Runx2 but not Lepr, nestin, Sox9, or Osx.
RNA proﬁling reveals that MMPs express a number of MSC
marker genes, including CD44, CD106/Vcam1, and CD146/
Mcam. β-Catenin is a critical modulator for fate decisions in
MMPs as deletion of β-catenin leads to excessive adipogenesis at
the expense of osteoblast differentiation. MMPs are transient as
they are abundant in juvenile mice but greatly diminished by
4 months of age when the cancellous bone is notably reduced.
However, the number of MMP-derived marrow adipocytes and
BMSCs increases with time, and about half of the MMP-derived
BMSCs express Lepr detectable by immunostaining in the adult
mice. Considering that Lepr+ BMSCs produce osteoblasts in older
adult mice, it is reasonable to postulate that MMP-derived Lepr+
BMSCs may serve as long-term osteoblast progenitors. Overall,
MMP cells on the one hand are transient progenitors to support
cancellous bone formation in young mice but on the other hand
likely give rise to long-term bone marrow progenitors to produce
bone marrow stroma, adipocytes as well as osteoblasts in adult
mice.
Besides normal bone formation, postnatal Gli1+ cells also
contribute to both chondrocyte and osteoblast production during
bone fracture healing. It is difﬁcult at present to discern the
physical location of Gli1+ cells responsible for the de novo for-
mation of chondrocytes and osteoblasts. Previous studies have
indicated that both BMSCs and periosteal cells expressing alpha-
smooth muscle actin (αSMA) contribute to the fracture callus15.
Thus either MMP-derived BMSCs or the Gli1-lineage cells in the
periosteum, or both, could produce osteoblasts and/or chon-
drocytes during fracture healing. Because we have observed only a
small number of Gli1-lineage cells in the periosteum of the
countralateral unfractured femur, we speculate that the Gli1-
lineage periosteal cells might rapidly expand in response to the
fracture. Finally, as we have observed Gli1-lineage cells in the
adjacent skeletal muscle, it cannot be ruled out that skeletogenic
progenitors could arrive from the muscle.
The current study has extended our understanding about Hh
signaling in the skeleton. Although previous work has docu-
mented extensively the essential role of Hh signaling in osteoblast
differentiation in the embryo, its physiological function in post-
natal bone formation remains unclear. Here, by deleting Smo
speciﬁcally in the Hh-responsive cells, we provide clear evidence
that Hh signaling is necessary for modulating the MMP pool by
promoting both proliferation and osteoblast differentiation in
postnatal mice. Although we have not investigated the source of
Hh protein in this setting, Ihh from the prehypertrophic chon-
drocytes is likely responsible for regulating the MMP population.
Overall, our study supports the notion that all cells destined to
become osteoblasts in the mouse likely experience Hh signaling at
an early precursor stage. In this regard, it is interesting to note
that Gli1-lineage cells were also a major source of osteoblast-like
cells during vascular calciﬁcation in a mouse model of chronic
kidney disease33. Although the molecular mechanism for this
apparent “rite of passage” for osteoblasts remains to be elucidated
in the future, the ﬁnding could be instructive for producing
osteoblasts from naive mesenchymal progenitors in the context of
regenerative medicine.
Methods
Mice. Mouse strains Gli1-CreERT2, Ai9, ColI-Gfp, Pdgfra-Gfp, Rosa-DTA,
β-cateninc/c, and Smoc/c are as described27, 34–39. All mice were maintained in a
speciﬁc pathogen-free facility, and Washington University Institutional Animal
Care and Use Committee approved all experimental procedures.
TM administration. For embryonic studies, TM (Sigma) (4 mg/30 g body weight,
dissolved in corn oil) was administered once by oral gavage to the dam at E13.5.
For postnatal studies, TM (5 mg, dissolved in corn oil) was administered once daily
for 3 consecutive days by oral gavage. Both males and females were used in lineage-
tracing experiments and no sex-dependent difference was observed. Sex-matched
littermates were used for comparison between experimental groups.
Immunoﬂuorescence staining. Immunoﬂuorescence staining was performed
according to a published procedure40. Brieﬂy, mice were perfused with 4% par-
aformaldehyde (PFA), and dissected bones were further ﬁxed with 4% PFA
overnight at room temperature and partially decalciﬁed in 14% EDTA for 3 days
with daily change of solution. The bones were then inﬁltrated with 30% sucrose
overnight at 4 °C for cryoprotection and embedded in optimal cutting temperature
(Tissue-Tek). Sections of 10-µm thickness were prepared with a Leica cryostat
equipped with Cryojane (Leica, IL). Lepr staining was performed with sections of
80-µm thickness. The sections were kept at 20 °C until use. For immunostaining of
both intracellular and extracellular aggrecan, slides were pretreated with hyalur-
onidase (Sigma, H4272, 2 mg/ml) at 37 °C for 20 min before antibody staining. The
antibodies used in this study are as follows: Osx (ab22552, Abcam, 1:100), Endo-
mucin (sc-65495, Santa Cruz Biotech. 1:100), Osteocalcin (sc-300045, Santa Cruz
Biotech. 1:50), Aggrecan (ab1031, Millipore, 1:100), Perilipin (9349, Cell Signaling
Technology, 1:100), and goat-anti-Lepr-biotin (R&D, 1:200). The secondary anti-
bodies include goat anti-rabbit Alexa Fluor 647, goat anti-rabbit Alexa Fluor 488,
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donkey anti-goat Alexa Fluor 488, and goat anti-rat Alexa Fluor 488 (Thermo-
Fisher Scientiﬁc, 1:200). Slides were mounted with antifade mounting medium with
DAPI (Vector Laboratories), and images were acquired with a confocal microscope
(Nikon C-1 confocal system).
Histology and histomorphometry. For histology, femora and tibiae were isolated
from mice after perfusion with 4% PFA and ﬁxed in 10% buffered formalin
overnight at room temperature, followed by decalciﬁcation in 14% EDTA for
2 weeks. After decalciﬁcation, femora and tibiae were processed for parafﬁn
embedding and then sectioned at 6-μm thickness. Hematoxylin and eosin (H&E)
staining was performed on parafﬁn sections according to the standard procedure.
Preparation of cells for FACS analyses. Whole bone marrow was gently ﬂushed
from the femur in a phosphate-buffered saline (PBS) buffer supplemented with
20% fetal bovine serum (FACS Buffer) and then treated with red cell lysis buffer at
room temperature for 5 min. The bone marrow cells were then centrifuged and re-
suspended in FACS Buffer. Cells from the cancellous bone region of long bones
were isolated as follows. Upon removal of the epiphysis, the metaphyseal bone
region extending about 5 mm from the growth plate was dissected and crushed
with mortar and pestle in FACS Buffer, followed by digestion with 0.25% col-
lagenase type I (C0130, Sigma-Aldrich) in PBS (Gibco) for 20 min at 37 °C with
gentle shaking. The cells were then centrifuged and re-suspended with FACS Buffer
and ﬁltered with a 70-µm cell strainer.
Flow cytometry. Cells re-suspended in 100 µl FACS Buffer were incubated with Fc
blocker anti-CD16/32 antibody (101319, Biolegend) for 10 min on ice, followed by
staining with ﬂuorochrome-conjugated antibody on ice for 30 min. The antibodies
used in this study include anti-mouse CD140a (Pdgfra) APC (17-1401-81,
eBioscience, 1:100), goat-anti-Lepr-biotin (AF497, R&D, 1:100), anti-Ter119-PE-
cy7 (25-5921-81, eBioscience, 1:1000), anti-CD31-PE-cy7 (25-0311-81,
eBioscience, 1:1000), and anti-CD31-PE-cy7 (25-0451-81, eBioscience, 1:1000).
Samples stained with biotin-conjugated antibodies were washed with FACS Buffer
and then incubated with streptavidin-brilliant violet 421 (Biolegend, 1:500) for 20
min. Flow cytometric analyses were carried out with an Lsr Fortessa ﬂow cytometer
equipped with the FACS Diva 6.1 software (BD Biosciences). Data were analyzed
with FlowJo version 9.
FACS sorting and RNA sequencing. Cells from the cancellous bone region were
isolated and stained as described above. The cells were then sorted with BD
FACSAriaII-1 (Department of Pathology and Immunology, Washington University
in St. Louis) for CD31−CD45−Ter119−tdTomato+ (Gli1+) cells vs. CD31−CD45
−Ter119−tdTomato− (Gli1−) cells. Sorted cells from multiple mice were pooled so
that a sufﬁcient amount of RNA can be extracted in each preparation with the
NucleoSpin RNA XS Kit (740902.50, Macherey-Nagel). RNA from three paired
pools of Gli1+ or Gli1− cells (each pair from the same group of mice) was subjected
to RNA-seq at the Genome Technology Access Center (GTAC, Washington
University in St. Louis). RNA-seq reads were aligned to the Ensembl release 76 top-
level assembly with STAR version 2.0.4b. Gene counts were derived from the
number of uniquely aligned unambiguous reads by Subread:featureCount version
1.4.5. Transcript counts were produced by Sailﬁsh version 0.6.3. Sequencing per-
formance was assessed for total number of aligned reads, total number of uniquely
aligned reads, genes and transcripts detected, ribosomal fraction known junction
saturation, and read distribution over known gene models with RSeQC version 2.3.
All gene-level and transcript counts were then imported into the
R/Bioconductor package EdgeR and TMM normalization size factors were calcu-
lated to adjust for samples for differences in library size. Genes or transcripts not
expressed in any sample were excluded from further analysis. The TMM size
factors and the matrix of counts were then imported into R/Bioconductor package
Limma and weighted likelihoods based on the observed mean–variance relation-
ship of every gene/transcript and sample were then calculated for all samples with
the voomWithQualityWeights function. Performance of the samples was assessed
with a spearman correlation matrix and multi-dimensional scaling plots. Gene/
transcript performance was assessed with plots of residual standard deviation of
every gene to their average log-count with a robustly ﬁtted trend line of the resi-
duals. Generalized linear models were then created to test for gene/transcript level
differential expression. Differentially expressed genes and transcripts were then
ﬁltered for false discovery rate-adjusted p-values ≤0.05. Heatmaps of select genes
were generated from voom transformed values with Heatmap3 package from R/
Bioconductor. The full dataset for RNA-seq was submitted to NCBI (SRA) (Bio-
ProjectID: PRJNA396564).
MicroCT and in vivo microCT. The femurs were scanned with a µCT system (µCT
40; Scanco Medical AG) following the recommendations by American Society for
Bone and Mineral Research41. For quantifying trabecular bone parameters, 100 CT
slices (1.6 mm total) immediately proximal to the distal femoral growth plate were
analyzed. For quantifying cortical bone parameters, 50 slices (0.8 mm total) at the
mid-diaphysis (starting from 6.8 mm proximal to the distal femoral articular
surface) were analyzed. To monitor bone growth with time, in vivo microCT
(vivaCT 40; Scanco Medical) was used to scan the femurs in live mice. For
quantifying trabecular bone parameters, 60 slices (1.2 mm total) immediately
proximal to the the distal femoral growth plate were analyzed (threshold set at
220).
Serum CTX-I and P1NP assays. For serum cross-linked CTX-I and amino-
terminal P1NP assays, serum was collected from mice after 6 h of fasting. Assays
were performed with the RatLaps ELISA or Rat/Mouse P1NP EIA Kit (both from
Immunodiagnostic Systems, Ltd.).
Proliferation assay. EdU was injected intraperitoneally at 10 μg/g body weight at
4 h before harvest. Frozen sections were subjected to a click reaction according to
the manufacturer’s instructions (Click-iT EdU Alexa Fluor 488 Imaging Kit,
Invitrogen).
Bone fracture. Fracture-healing studies were performed with 10-week-old mice by
using a semistabilized femur fracture model as previously described42. Brieﬂy,
anesthetized mice were prepared for surgery by shaving the fur around the knee
area and disinfecting the skin with Betadine. An incision was made to dislocate the
patella and the intramedullary canal was accessed by creating a hole in the distal
end of the femur. A guidewire was placed into the femur and the mouse secured
into custom three-point bending ﬁxtures on a material testing machine (Dyna-
might 8841, Instron). The femur was broken using a controlled displacement ramp.
Then the femur was stabilized with a 24-gauge stainless steel pin that was posi-
tioned over the guidewire. The guidewire was removed, rod trimmed, and the
wound sutured and closed. Animals were given Buprenex to alleviate any surgical
pain. Radiographs were taken immediately following surgery and prior to sacriﬁce
to conﬁrm pin stability. Mice were analyzed 10 days after bone fracture.
Statistics. Quantitative data were evaluated by paired Student’s t-tests. p < 0.05
was considered statistically signiﬁcant.
Data availability. The full dataset for RNA-seq supporting the molecular proﬁle of
Gli1+ MMP is available at NCBI (SRA) (BioProjectID: PRJNA396564).
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